ENT (Otorhinolaryngology) in Pennsylvania

Earflo Inc. develops an innovative, non-invasive medical device for treating negative middle ear pressure (eustachian tube dysfunction) in children aged two and older. The device is designed to resemble a child's sippy cup and works by sensing swallowing and delivering gentle air pressure to the nasopharynx, helping to open the eustachian tube and allow trapped fluid to drain naturally. This approach addresses otitis media with effusion and chronic ear infections while avoiding surgical intervention. The company's product is intended to prevent hearing loss, reduce pain and behavioral/sleep disruption, and minimize developmental delays associated with untreated middle ear pressure disorders. Earflo was developed by biomedical engineers and ENT specialists and has received recognition as Best of Innovation in Digital Health at CES 2026. The device is FDA 510(k) pending and includes a companion mobile app to support treatment compliance and engagement. The product targets pediatric patients and their families seeking non-surgical management of common ear conditions. Currently not available for commercial purchase; the company is in the regulatory approval phase.

MG Development America Inc. is a subsidiary of MG Développement, a French medical device manufacturer with over 20 years of experience designing, developing, and producing customized medical devices for hearing aid maintenance and care. The company specializes in both conventional and electronic maintenance solutions specifically tailored for hearing aid upkeep, compliant with EU Regulation 2017/745. Product offerings include cleaning sprays, starter kits, dehydration tablets, and proprietary systems such as PerfectClean and PerfectDome. All products are engineered to minimize risks to hearing aids and reduce allergy concerns. MG Development provides comprehensive B2B support including custom product personalization, R&D services, global supply chain management, and inventory optimization. The company partners with audiologists, hearing aid dispensers, and manufacturers to systematize hearing aid maintenance and reduce warranty returns through effective hygiene solutions.

UltraVoice manufactures custom-fitted, non-invasive speaking systems for laryngectomees and individuals with voice loss. The UltraVoice Plus is a hands-free electrolaryngeal device that captures natural tone and inflection, projecting speech directly from the mouth without requiring neck placement or surgical intervention. Unlike traditional handheld artificial larynx devices, UltraVoice provides real-time, spontaneous speech with natural pitch variation and conversation flow comparable to speech-generating devices but without typing delay. The system serves as a non-surgical alternative to tracheoesophageal puncture (TEP) voice prostheses, eliminating risks associated with prosthesis displacement or frequent medical replacements. Each device is custom-fitted to individual patient anatomy to optimize comfort, fit, and speaking performance. UltraVoice requires no ongoing surgical procedures or medical interventions, uses an oral mouthpiece interface with lightweight electronic components, and is designed for simple operation and maintenance. The company has served the laryngectomy community for more than 30 years, positioning the device as a reliable, everyday speaking solution that supports patient independence, social connection, and communication dignity. The technology bridges the gap between traditional artificial larynx devices and speech-generating devices, offering spontaneous, natural-sounding speech restoration.

TalexMedical, LLC manufactures and distributes the InfantEar™ Molding System, a non-surgical medical device for the treatment of congenital ear deformities in neonates and infants. The InfantEar™ system is a single-use, disposable kit containing soft, biocompatible silicone materials that conform to individual ear anatomy. The device is customizable during application and accommodates ears of all sizes. Treatment typically requires 2–3 weeks of molding time when initiated within the first two weeks of life, with most cases requiring a single application. The system treats a wide range of ear anomalies including helical rim deformity, cryptotia, prominent ears, constricted ears, Stahl's deformity, and cup/lop/lidded ears. The product features a 3-year shelf life, clear silicone matrix for visibility during therapy, and is designed for office-based application by healthcare professionals without need for external referrals or costly surgical intervention. The device is non-sterile, pain-free, and minimizes the need for multiple office visits. TalexMedical positions InfantEar™ as an alternative to traditional surgical correction, offering improved access to treatment and reduced patient costs. The company provides clinical support, provider locator services, and educational resources for both healthcare professionals and parents/guardians.